BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
(Q27650860)
scientific article
scientific article
Language:
Current Data About
BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
(P31) |
(Q13442814)
|
||||||||||||||||||||
(P50) |
(Q28468911)
(Q89545888)
|
||||||||||||||||||||
(P304) |
4774-82
|
||||||||||||||||||||
(P407) |
(Q1860)
|
||||||||||||||||||||
(P433) |
12
|
||||||||||||||||||||
(P478) |
68
|
||||||||||||||||||||
(P577) |
Sunday, June 15, 2008
|
||||||||||||||||||||
(P1433) |
(Q326097)
|
||||||||||||||||||||
(P1476) |
"BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy" (language: en)
|
||||||||||||||||||||
(P2093) |
Frank Hilberg
Gerald J Roth
Susanna Kautschitsch
Wolfgang Sommergruber
Ulrike Tontsch-Grunt
Gerd Bader
Andreas Zoephel
Jens Quant
Armin Heckel
Wolfgang J Rettig
|